杆菌和口腔肠道微生物组:临床影响
Maged T Elghannam1, Moataz H Hassanien2, Yosry A Ameen2
1Hepatogastroenterology Department, Theodor Bilharz Research Institute, Giza, Egypt. maged_elghannam@yahoo.com.
Infection
|November 2, 2023
概括
杆菌 (H. pylori) 感染与胃癌有关,但根除疗法可能会损害肠道微生物群. 益生菌增强疗法可以改善H. pylori的根除,并减少副作用.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
背景情况:
- 杆菌 (H. pylori) 殖民全球一半以上的人口,地理分布不同.
- 杆菌与胃炎,和胃癌有关,被归类为第一类致癌物.
- 这种细菌与口腔肠轴沿线的Bacteroidetes和Fusobacteria共存.
研究的目的:
- 评估H. pylori根除治疗对口腔和肠道微生物群的影响.
- 探索将益生菌纳入H. pylori根除方案的好处.
- 评估H. pylori在各种非胃疾病中的潜在保护作用.
主要方法:
- 对H. pylori感染及其与胃病相关性的分析.
- 研究根除治疗对肠道和口腔微生物群的影响.
- 在根除治疗期间对益生菌,益生菌和草药补充剂的研究的审查.
主要成果:
- 根除疗法可能会对肠道微生物群多样性产生负面影响,并促进有害的口腔细菌.
- 益生菌综合疗法比标准疗法具有更高的根除率和更少的副作用.
- 杆菌已经证明在喘和多发性硬化症等疾病中具有潜在的保护作用.
结论:
- 杆菌根除疗法需要仔细考虑,特别是在高流行率地区.
- 益生菌补充剂可以减轻根除疗法的负面微生物影响.
- 消除效益与风险之间的平衡至关重要,尤其对脆弱人群来说.
更多相关视频
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
419
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
419
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
136
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
136
Peptic Ulcer Disease I: Introduction
179
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
179
What is Monogastric Digestion?
71.3K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.3K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
605
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
605
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
438
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
438


